# Jasper Therapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2025

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 10-K/A
- Filed: 2026-04-30
- Accepted by EDGAR: Apr 30, 2026, 16:01 ET
- Period: 2025-12-31
- Accession: 0001213900-26-050178
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390026050178/ea0287356-10ka1_jasper.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390026050178/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390026050178/ea0287356-10ka1_jasper.htm

Filed Apr 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-050178. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.